Birong Cao

428 total citations · 1 hit paper
5 papers, 265 citations indexed

About

Birong Cao is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Birong Cao has authored 5 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Infectious Diseases. Recurrent topics in Birong Cao's work include Neuroscience and Neuropharmacology Research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Birong Cao is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Birong Cao collaborates with scholars based in China, Italy and Hong Kong. Birong Cao's co-authors include Bingbing He, Xue Dong, Weiya Bai, Zikang Wang, Qingquan Xiao, Yifan Wang, Chunlong Xu, Jinsheng Lai, Xiaona Huo and Tanglong Yuan and has published in prestigious journals such as Nature Methods, International Journal of Cancer and Neurobiology of Disease.

In The Last Decade

Birong Cao

4 papers receiving 261 citations

Hit Papers

Programmable RNA editing with compact CRISPR–Cas13 system... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes
    2021 232 citations Chunlong Xu, Yingsi Zhou et al. Nature Methods profile →

Peers

Birong Cao
Dexuan Cui Hong Kong
Sneha Suresh United States
Andreas Blaha Germany
Chih-Chung Kuo United States
Shengyao Zhi China
Keewon Sung South Korea
Zongyi Yi China
Oana Pelea United Kingdom
Pietro De Angeli Germany
Philipp Kanis Germany
Dexuan Cui Hong Kong
Birong Cao
Citations per year, relative to Birong Cao Birong Cao (= 1×) peers Dexuan Cui

Countries citing papers authored by Birong Cao

Since Specialization
Citations

This map shows the geographic impact of Birong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birong Cao more than expected).

Fields of papers citing papers by Birong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birong Cao. The network helps show where Birong Cao may publish in the future.

Co-authorship network of co-authors of Birong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Birong Cao. A scholar is included among the top collaborators of Birong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birong Cao. Birong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Cao, Birong, et al.. (2024). The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations. mBio. 15(5). e0318723–e0318723.
2.
Wu, Pengpeng, et al.. (2023). Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil. Neuroscience Bulletin. 40(5). 594–608. 11 indexed citations
3.
Cao, Birong, Haiyan Xu, Li Zhan, et al.. (2022). Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation. Neurobiology of Disease. 174. 105860–105860. 7 indexed citations
4.
Xu, Chunlong, Yingsi Zhou, Qingquan Xiao, et al.. (2021). Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes. Nature Methods. 18(5). 499–506. 232 indexed citations breakdown →
5.
Wang, Xiaodong, Birong Cao, Ji Zhou, et al.. (2020). A chemical conjugation of JQ‐1 and a TLR7 agonist induces tumoricidal effects in a murine model of melanoma via enhanced immunomodulation. International Journal of Cancer. 148(2). 437–447. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dexuan Cui Breakdown of academic impact, for papers by Sneha Suresh Breakdown of academic impact, for papers by Andreas Blaha Breakdown of academic impact, for papers by Chih-Chung Kuo Breakdown of academic impact, for papers by Shengyao Zhi Breakdown of academic impact, for papers by Keewon Sung Breakdown of academic impact, for papers by Zongyi Yi Breakdown of academic impact, for papers by Oana Pelea Breakdown of academic impact, for papers by Pietro De Angeli Breakdown of academic impact, for papers by Philipp Kanis
Rankless by CCL
2026